Cipla Quality Chemicals Industries Limited (CIPLA.ug) 2021 Annual Report

Cipla Quality Chemicals Industries Limited (CIPLA.ug) listed on the Uganda Securities Exchange under the Pharmaceuticals sector has released it’s 2021 annual report.

For more information about Cipla Quality Chemicals Industries Limited (CIPLA.ug) reports, abridged reports, interim earnings results and earnings presentations visit the Cipla Quality Chemicals Industries Limited (CIPLA.ug) company page on AfricanFinancials.

Indicative Share Trading Liquidity

The total indicative share trading liquidity for Cipla Quality Chemicals Industries Limited (CIPLA.ug) in the past 12 months, as of 5th August 2022, is US$5.3K (UGX64.29M). An average of US$442 (UGX5.36M) per month.

Cipla Quality Chemicals Industries Limited 2021 annual report

Company Profile

Cipla Quality Chemical Industries Limited is a pharmaceutical manufacturing company located in Kampala, Uganda. The company manufactures Anti-retroviral (ARVs), Artemisinin-based Combination Therapies (ACTs) and Hepatitis medicines to treat HIV/AIDS, Malaria and Hepatitis. Cipla Quality Chemicals Industries Limited is listed on the Uganda Securities Exchange